Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Talbot J, Højsgaard Chow H, Mahler M, Buhelt S, Holm Hansen R, Lundell H, Vinther-Jensen T, Hellem MNN, Nielsen JE, Siebner HR, von Essen MR, Sellebjerg F. Talbot J, et al. Among authors: siebner hr. Mult Scler Relat Disord. 2022 Dec;68:104209. doi: 10.1016/j.msard.2022.104209. Epub 2022 Oct 3. Mult Scler Relat Disord. 2022. PMID: 36257152 Free article. Clinical Trial.
Interpolation of diffusion weighted imaging datasets.
Dyrby TB, Lundell H, Burke MW, Reislev NL, Paulson OB, Ptito M, Siebner HR. Dyrby TB, et al. Among authors: siebner hr. Neuroimage. 2014 Dec;103:202-213. doi: 10.1016/j.neuroimage.2014.09.005. Epub 2014 Sep 16. Neuroimage. 2014. PMID: 25219332 Free article.
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
Ratzer R, Iversen P, Börnsen L, Dyrby TB, Romme Christensen J, Ammitzbøll C, Madsen CG, Garde E, Lyksborg M, Andersen B, Hyldstrup L, Sørensen PS, Siebner HR, Sellebjerg F. Ratzer R, et al. Among authors: siebner hr. Mult Scler. 2016 Jun;22(7):926-34. doi: 10.1177/1352458515605908. Epub 2015 Oct 2. Mult Scler. 2016. PMID: 26432857 Clinical Trial.
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Schreiber K, Magyari M, Sellebjerg F, Iversen P, Garde E, Madsen CG, Börnsen L, Romme Christensen J, Ratzer R, Siebner HR, Laursen B, Soelberg Sorensen P. Schreiber K, et al. Among authors: siebner hr. Mult Scler. 2017 Apr;23(5):675-685. doi: 10.1177/1352458516661048. Epub 2016 Aug 5. Mult Scler. 2017. PMID: 27481206 Clinical Trial.
519 results